J Low Genit Tract Dis. 2014;18(1):1-7. In a clinical setting, this combination of maintained sensitivity with increased specificity would lead to fewer office visits and procedures. Our cost analysis ...
The second motivating factor for the development of new management guidelines is the important data from the NCI-supported ALTS trial published in the Fall of 2001. This trial randomized patients with ...
(HealthDay News) – DNA-based testing with Hybrid Capture 2 (HC2) assay is more accurate than repeat cytology in identifying women with cervical cancer when their initial Pap smear shows atypical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback